Search
GWAS ID | Year | Trait | Consortium | Sample size | Number of SNPs |
---|---|---|---|---|---|
ebi-a-GCST90093466 | 2022 | Late-onset myasthenia gravis | NA | 34,930 | 22,357,218 |
ebi-a-GCST90093465 | 2022 | Early-onset myasthenia gravis | NA | 3,313 | 17,976,334 |
ebi-a-GCST90093378 | 2021 | Dementia with Lewy bodies in APOE e4+ carriers | NA | 1,837 | 5,912,161 |
ebi-a-GCST90093331 | 2020 | Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; all treatment preparations) | NA | 2,744 | 7,625,406 |
ebi-a-GCST90093330 | 2020 | Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; IFN<U+03B2>-1b subcutaneous) | NA | 1,008 | 7,973,212 |
Data overview
The GWAS summary datasets are currently organised into the following 18 batches: